Tag: Biomedical materials

Biologics Act in the United States Biologics Act 2009, the FDA and Patent Litigation by Rene Ciria-Cruz (2011) The era of mega patent battles over biologics, a new breed of biotech drugs, loomed ever larger last fall when Israel’s Teva Pharmaceutical Industries launched a second clinical […]